Asexual sporulation facilitates adaptation: The emergence of azole resistance in Aspergillus fumigatus

Evolution; International Journal of Organic Evolution
Jianhua ZhangS E Schoustra

Abstract

Understanding the occurrence and spread of azole resistance in Aspergillus fumigatus is crucial for public health. It has been hypothesized that asexual sporulation, which is abundant in nature, is essential for phenotypic expression of azole resistance mutations in A. fumigatus facilitating subsequent spread through natural selection. Furthermore, the disease aspergilloma is associated with asexual sporulation within the lungs of patients and the emergence of azole resistance. This study assessed the evolutionary advantage of asexual sporulation by growing the fungus under pressure of one of five different azole fungicides over seven weeks and by comparing the rate of adaptation between scenarios of culturing with and without asexual sporulation. Results unequivocally show that asexual sporulation facilitates adaptation. This can be explained by the combination of more effective selection because of the transition from a multicellular to a unicellular stage, and by increased mutation supply due to the production of spores, which involves numerous mitotic divisions. Insights from this study are essential to unravel the resistance mechanisms of sporulating pathogens to chemical compounds and disease agents in general, and for de...Continue Reading

References

Jan 1, 1973·The Journal of Heredity·E Käfer, A Upshall
Jul 21, 1994·Nature·A S Kondrashov
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·R E Lenski, M Travisano
Jun 1, 1993·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M L Springer
Apr 15, 1997·FEMS Microbiology Letters·T Joseph-Horne, D W Hollomon
Aug 1, 1997·Infection and Immunity·J P DebeaupuisJ P Latgé
Apr 8, 1998·Microbiology and Molecular Biology Reviews : MMBR·T H AdamsJ H Yu
Apr 9, 1999·Clinical Microbiology Reviews·J P Latgé
Jul 14, 2001·Radiographics : a Review Publication of the Radiological Society of North America, Inc·T FranquetS Bagué
Sep 5, 2002·Nature Reviews. Genetics·Lorna Casselton, Miriam Zolan
Oct 16, 2002·Trends in Microbiology·Anne Pringle, John Taylor
Jan 21, 2004·Fungal Genetics and Biology : FG & B·Judith BruggemanRolf F Hoekstra
Jun 20, 2006·Journal of Evolutionary Biology·S E SchoustraR F Hoekstra
Jul 22, 2006·Science·Anna SelmeckiJudith Berman
Oct 13, 2006·Eukaryotic Cell·Jae-Hyung Mah, Jae-Hyuk Yu
Oct 13, 2006·International Journal of Antimicrobial Agents·Susan J HowardDavid W Denning
Oct 20, 2006·Medical Mycology·Judith C Rhodes
May 1, 2007·PLoS Genetics·Sijmen E SchoustraRolf F Hoekstra
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Richard E Michod
Apr 21, 2009·Applied and Environmental Microbiology·Eveline SneldersPaul E Verweij
Jul 15, 2009·Clinical Microbiology Reviews·Taylor R T Dagenais, Nancy P Keller
Jul 25, 2009·Emerging Infectious Diseases·Susan J HowardDavid W Denning
Nov 21, 2009·The Lancet Infectious Diseases·Paul E VerweijWillem J G Melchers
Dec 4, 2009·PLoS Biology·Sijmen E SchoustraRees Kassen
May 25, 2010·Eukaryotic Cell·Anna SelmeckiJudith Berman
Aug 24, 2010·The Journal of Antimicrobial Chemotherapy·Ahmed BueidDavid W Denning
Sep 2, 2010·Antimicrobial Agents and Chemotherapy·Klaus Leth MortensenMaiken Cavling Arendrup

❮ Previous
Next ❯

Citations

Jan 20, 2016·Current Genetics·Elixabet Oiartzabal-AranoOier Etxebeste
Oct 11, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Adilson Vidal CostaWaldir Cintra de Jesus Júnior
Apr 24, 2016·Antimicrobial Agents and Chemotherapy·Jochem B BuilPaul E Verweij
Nov 2, 2019·Journal of Applied Microbiology·R J M LubbersR P de Vries
May 28, 2020·Journal of Medical Microbiology·François DanionFanny Lanternier
Jan 13, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Jacques F MeisPaul E Verweij
Jul 16, 2020·Environmental Microbiology·Heidy Peidro-GuzmánRamón Alberto Batista-García
May 4, 2016·Fungal biology and biotechnology·Noah B Strom, Kathryn E Bushley
Apr 10, 2019·Proceedings. Biological Sciences·Jianhua ZhangAlfons J M Debets
Jun 19, 2019·Emerging Infectious Diseases·Sijmen E SchoustraPaul E Verweij
Dec 15, 2020·ERJ Open Research·Tobias EngelEveline Snelders
Dec 24, 2018·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P P A LestradeP E Verweij

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.